Nuwellis (NUWE) Shareholder's Equity Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -42.04% |
| Dec 31, 2025 | -40.34% |
| Sep 30, 2025 | -34.67% |
| Jun 30, 2025 | -35.85% |
| Mar 31, 2025 | -45.18% |
| Dec 31, 2024 | -36.87% |
| Sep 30, 2024 | -52.68% |
| Jun 30, 2024 | -31.29% |
| Mar 31, 2024 | -69.22% |
| Dec 31, 2023 | -43.20% |
| Sep 30, 2023 | -27.21% |
| Jun 30, 2023 | 4.87% |
| Mar 31, 2023 | 21.05% |
| Dec 31, 2022 | 83.80% |
| Sep 30, 2022 | 47.84% |
| Jun 30, 2022 | 27.94% |
| Mar 31, 2022 | 20.12% |
| Dec 31, 2021 | 63.51% |
| Sep 30, 2021 | 45.90% |
| Jun 30, 2021 | 43.44% |
| Mar 31, 2021 | 34.82% |
| Dec 31, 2020 | 0.16% |
| Sep 30, 2020 | 42.80% |
| Jun 30, 2020 | 0.34% |
| Mar 31, 2020 | 25.99% |
| Dec 31, 2019 | 4.24% |
| Sep 30, 2019 | 20.81% |
| Jun 30, 2019 | 31.74% |
| Mar 31, 2019 | 18.07% |
| Dec 31, 2018 | -21.29% |
| Sep 30, 2018 | -19.40% |
| Jun 30, 2018 | -28.91% |
| Mar 31, 2018 | -25.60% |
| Dec 31, 2017 | -17.78% |
| Sep 30, 2017 | -41.61% |
| Jun 30, 2017 | -38.33% |
| Mar 31, 2017 | -56.32% |
| Dec 31, 2016 | -67.61% |
| Sep 30, 2016 | -65.10% |
| Jun 30, 2016 | -43.44% |
| Mar 31, 2016 | -8.40% |
| Dec 31, 2015 | -2.04% |
| Sep 30, 2015 | 4.11% |
| Jun 30, 2015 | 236.26% |
| Mar 31, 2015 | 116.85% |
| Dec 31, 2014 | 85.24% |